125 related articles for article (PubMed ID: 9865512)
21. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine.
Walker LM; Walker PD; Imam SZ; Ali SF; Mayeux PR
J Pharmacol Exp Ther; 2000 Oct; 295(1):417-22. PubMed ID: 10992009
[TBL] [Abstract][Full Text] [Related]
22. Effects of S-isopropyl isothiourea, a potent inhibitor of nitric oxide synthase, in severe hemorrhagic shock.
Vromen A; Szabó C; Southan GJ; Salzman AL
J Appl Physiol (1985); 1996 Aug; 81(2):707-15. PubMed ID: 8872637
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.
Chatterjee PK; Patel NS; Kvale EO; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
Kidney Int; 2002 Mar; 61(3):862-71. PubMed ID: 11849439
[TBL] [Abstract][Full Text] [Related]
24. [Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats].
Albornoz L; Bandi JC; de las Heras M; Mastai R
Medicina (B Aires); 2000; 60(4):477-81. PubMed ID: 11188955
[TBL] [Abstract][Full Text] [Related]
25. The role of inducible nitric oxide synthase inhibitor on the arteriolar hyporesponsiveness in hemorrhagic-shocked rats.
Md S; Moochhala SM; Siew-Yang KL
Life Sci; 2003 Aug; 73(14):1825-34. PubMed ID: 12888121
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
Bryk R; Wolff DJ
Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001
[TBL] [Abstract][Full Text] [Related]
27. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.
Moore WM; Webber RK; Jerome GM; Tjoeng FS; Misko TP; Currie MG
J Med Chem; 1994 Nov; 37(23):3886-8. PubMed ID: 7525961
[TBL] [Abstract][Full Text] [Related]
28. The influence of phosphodiesterase inhibitor, rolipram, on hemodynamics in lipopolysaccharide-treated rats.
Dutta P; Ryan DE; Tabrizchi R
Jpn J Pharmacol; 2001 Mar; 85(3):241-9. PubMed ID: 11325016
[TBL] [Abstract][Full Text] [Related]
29. Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats.
Hsu YH; Hsu BG; Chen HI
Chin J Physiol; 2007 Dec; 50(6):283-93. PubMed ID: 18442011
[TBL] [Abstract][Full Text] [Related]
30. Selective inducible nitric oxide synthase (iNOS) inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic aneurysm.
Harkin DW; Rubin BB; Romaschin A; Lindsay TF
J Surg Res; 2004 Aug; 120(2):230-41. PubMed ID: 15234218
[TBL] [Abstract][Full Text] [Related]
31. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase.
Connor JR; Manning PT; Settle SL; Moore WM; Jerome GM; Webber RK; Tjoeng FS; Currie MG
Eur J Pharmacol; 1995 Jan; 273(1-2):15-24. PubMed ID: 7537678
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide synthase inhibitor increases hepatic injury with formation of oxidative DNA damage and microcirculatory disturbance in endotoxemic rats.
Takemura S; Minamiyama Y; Inoue M; Kubo S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 2000; 47(35):1364-70. PubMed ID: 11100353
[TBL] [Abstract][Full Text] [Related]
33. The attenuation of hemorrhage-induced liver injury by exogenous nitric oxide, L-arginine, and inhibition of inducible nitric oxide synthase.
Anaya-Prado R; Toledo-Pereyra LH; Guo RF; Reuben J; Ward PA; Walsh J
J Invest Surg; 2003; 16(5):247-61. PubMed ID: 14527883
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion.
Howdieshell TR; Webb WL; Sathyanarayana ; McNeil PL
Surgery; 2003 May; 133(5):528-37. PubMed ID: 12773981
[TBL] [Abstract][Full Text] [Related]
35. Highly selective iNOS inhibition and sphincter of Oddi motility in the Australian possum.
Sandstrom P; Woods CM; Brooke-Smith M; Saccone GT; Toouli J; Svanvik J
Acta Physiol Scand; 2004 Jul; 181(3):321-31. PubMed ID: 15196093
[TBL] [Abstract][Full Text] [Related]
36. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
[TBL] [Abstract][Full Text] [Related]
37. Urinary nitrate excretion in cholesterol-fed rabbits: effect of a chronic treatment by N-iminoethyl-L-lysine, a selective inhibitor of inducible nitric oxide synthase.
Behr-Roussel D; Rupin A; Simonet S; Fabiani J; Verbeuren TJ
Eur J Pharmacol; 2000 Feb; 388(3):275-9. PubMed ID: 10675737
[TBL] [Abstract][Full Text] [Related]
38. The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization.
Stallmeyer B; Kämpfer H; Kolb N; Pfeilschifter J; Frank S
J Invest Dermatol; 1999 Dec; 113(6):1090-8. PubMed ID: 10594757
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
40. Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection.
Pieper GM; Nilakantan V; Hilton G; Zhou X; Khanna AK; Halligan NL; Felix CC; Kampalath B; Griffith OW; Hayward MA; Roza AM; Adams MB
Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H525-34. PubMed ID: 14715498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
